IM Cannabis (IMCC) Shares Outstanding (Diluted Average) (2019 - 2025)
IM Cannabis (IMCC) recorded quarterly Shares Outstanding (Diluted Average) of $3534.4 in Q3 2025, up 5441205.93% quarter-over-quarter from $0.06 in Q2 2025, and up 116.01% on a YoY basis from $1636.2 in Q3 2024.
IM Cannabis (IMCC) Shares Outstanding (Diluted Average) (2019 - 2025) Analysis & Trends
IM Cannabis' Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $3534.4 for Q3 2025.
- In Q3 2025, Shares Outstanding (Diluted Average) rose 116.01% year-over-year to $3534.4; the TTM figure through Sep 2025 stood at $3534.4 (up 116.01% YoY), while the FY2024 annual figure was $3.29, changed 0.12% from the prior year.
- Shares Outstanding (Diluted Average) was $3534.4 for Q3 2025 at IM Cannabis, up from $0.06 in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $3534.4 in Q3 2025 to a low of $0.05 in Q1 2021.
- Historically, Shares Outstanding (Diluted Average) has averaged $529.71 across 5 years, with a median of $1.8 in 2022.
- The sharpest annual moves came in 2021 and 2023: Shares Outstanding (Diluted Average) soared 4663.76% in 2021, then tumbled 97.26% in 2023.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $0.14 in 2021, then soared by 83300.52% to $119.26 in 2022, then sank by 97.26% to $3.27 in 2023, then fell by 1.23% to $3.23 in 2024, then surged by 109374.21% to $3534.4 in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $3534.4 (Q3 2025), $0.06 (Q2 2025), and $3.23 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | IM Cannabis | 57,090.22 | -728,264.31 | 1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3,534.35 |
| Jun 30, 2025 | 0.06 |
| Dec 31, 2024 | 3.23 |
| Sep 30, 2024 | 1,636.18 |
| Dec 31, 2023 | 3.27 |
| Dec 31, 2022 | 119.26 |
| Jun 30, 2022 | 0.37 |
| Sep 30, 2021 | 0.14 |
| Jun 30, 2021 | 0.19 |
| Mar 31, 2021 | 0.05 |
| Dec 31, 2020 | 0.38 |
| Sep 30, 2020 | 0.00 |
| Jun 30, 2020 | 0.38 |
| Mar 31, 2020 | 0.00 |
| Dec 31, 2019 | 0.01 |